LERØY SEAFOOD GROUP ASA: SOLID OPERATIONS AND GOOD BIOLOGICAL PERFORMANCE IN THE FOURTH QUARTER  «Operational EBIT in the fourth quarter of 2025 amounted to NOK 758 million. The result reflects good underlying operations across the Group, with solid contributions from Farming and a very strong quarter in the Value-Added Processing, Sales and Distribution (VAP S&D) segment. Although the year has been characterised by low salmon prices, the fourth quarter demonstrates the effect of a robust and fully integrated value chain», says Henning Beltestad, CEO of Lerøy Seafood Group. FARMING: IMPROVING PRICES TOWARDS THE END OF THE QUARTER AND GOOD BIOLOGICAL PERFORMANCE Operational EBIT in the farming segment amounted to NOK 564 million in the fourth quarter of 2025, somewhat lower than in the corresponding period last year. «Prices for salmon...

GUADALAJARA, Mexico, Feb. 23, 2026 (GLOBE NEWSWIRE) — Grupo Aeroportuario del Pacífico, S.A.B. de C.V. (NYSE: PAC; BMV: GAP) (“the Company” or “GAP”) reports its consolidated results for the fourth quarter ended December 31, 2025 (4Q25). Figures are unaudited and prepared following International Financial Reporting Standards (“IFRS”) as issued by the International Accounting Standards Board (“IASB”). Summary of Results 4Q25 vs. 4Q24The sum of aeronautical and non-aeronautical services revenues increased by Ps. 911.4 million, or 12.8%. Total revenues increased by Ps. 267.1 million, or 2.8%. Cost of services increased by Ps. 426.8 million, or 28.1%. Income from operations increased by Ps. 322.1 million, or 8.4%. EBITDA increased by Ps. 357.3 million, or 7.5%, an increase from Ps. 4,757.0 million in 4Q24 to Ps. 5,114.3 million in...

Record 4Q and Full Year Performance at Work Truck Solutions; Record Parts & Accessories Sales at Work Truck Attachments Full Year 2025 Highlights*Consolidated Net Sales increased 15.4% to $656.1 million Winter weather drove robust Parts & Accessories sales across the company, particularly in 4Q Delivered Diluted Earnings per Share (EPS) of $1.96; Adjusted Diluted EPS increased 52.0% to $2.24 Both segments produced Net Sales and Adjusted EBITDA growth for both 4Q and Full Year 2025   Acquired Venco Venturo in 4Q, a well-established provider of truck-mounted service cranes and dump hoists Outlined 2026 full year outlook with Adjusted EPS range of $2.25 – $2.85*Compared to full year 2024 financials. MILWAUKEE, Feb. 23, 2026 (GLOBE NEWSWIRE) — Douglas Dynamics, Inc. (NYSE: PLOW), North America’s premier manufacturer...

ONEOK Announces 2026 Financial GuidanceONEOK reports 11% increase in net income and 18% increase in adjusted EBITDA for full year 2025 compared to 2024.ONEOK, Inc.TULSA, Okla., Feb. 23, 2026 (GLOBE NEWSWIRE) — ONEOK, Inc. (NYSE: OKE) today announced fourth-quarter and full-year 2025 results and 2026 financial guidance. Unless otherwise noted, all results are compared with the same periods in 2024. Fourth-Quarter 2025 Results:Net income of $978 million, resulting in $1.55 per diluted share. Adjusted EBITDA of $2.15 billion. 15% increase in Rocky Mountain region NGL raw feed throughput volumes. 3% increase in Rocky Mountain region natural gas volumes processed.Higher Full-Year 2025 Results:Net income of $3.46 billion (includes noncontrolling interests). 12% increase in net income attributable to ONEOK to $3.39 billion,...

Achieves 20% worldwide revenue growth and positive adjusted EBITDA for Fiscal Year 2025Generates free cash flow in the Fourth Quarter 2025 SANTA CLARA, Calif., Feb. 23, 2026 (GLOBE NEWSWIRE) — SI-BONE, Inc. (Nasdaq: SIBN), the global leader in developing procedural solutions to address clinical challenges associated with compromised bone, today reported financial results for the fourth quarter and full year ended December 31, 2025. Fourth Quarter 2025 Financial Highlights (all comparisons are to the prior year period)Worldwide revenue of $56.3 million, representing growth of 15.0% U.S. revenue of $53.5 million, representing growth of 13.9% Gross margin of 79.0% Net loss of $1.6 million, representing an improvement of 63.3% Positive adjusted EBITDA of $5.1 million, representing an improvement of 176.2% Positive cashflow from operations...

Vastned concludes 2025 with a stable EPRA result, a decrease of the debt ratio below 40% and an increase in the proposed dividend. After completion of the reverse cross-border merger, the group operates with one listed entity and simplified governance. Vastned achieves the objectives of the reverse cross-border merger… ✔ An organizational simplification that improves the efficiency of the Vastned group with only one listed entity, one management and simplified governance.✔ An operational synergy worth € 2.0 million, with additional potential in 2026.✔ Optimized debt financing by signing credit refinancing in 2025 for an amount of € 395.0 million. ✔ Increased liquidity with the entry into the Euronext BEL Mid index in 2025. In January 2026, Vastned received the award of 2025 BEL MID Company of the year...

CLEARWATER, Fla., Feb. 23, 2026 (GLOBE NEWSWIRE) — via IBN — MedWell Ai, Inc, (OTCQB:MWAI) (“Company”) is a portfolio company, specializing in AI-driven solutions for B2B markets in pharmaceuticals, healthcare, and wellness, is pleased to confirm the filing, after the market close, of its Quarterly Report (Form 10-Q), for the financial period, ending on December 31, 2025. The Company reported $548,315 in Revenue for its fiscal second quarter of 2025. This performance was result of a successful strategic shift toward building an AI-driven healthcare, pharmaceutical and biological wellness portfolio.  Key Financial Highlights: Increased Total Revenues:For three months, ended December 31, 2025, Company had generated total revenues of 548,315 vs $142,861 for three months, ended December 31, 2024 (280%+ increase). For...

LAVAL, Quebec, Feb. 23, 2026 (GLOBE NEWSWIRE) — Savaria Corporation (“Savaria”) (TSX: SIS) one of the global leaders in the accessibility industry, announces it will release its financial results for the fourth quarter of 2025 after market closes on March 4, 2026. Savaria’s management will hold an investor conference call and webcast at 8:30 a.m. Eastern Standard Time (EST) on Thursday, March 5, 2026. Investors and members of the media are invited to participate on a listen-only basis. Conference call access: https://register-conf.media-server.com/register/BI11584c57606d4117a7bc686702e48569 To access the conference call, you must register online and choose the method to join the call, either by dialing the number provided to you or by entering your phone number to receive a call from the system. Webcast URL (EN): https://edge.media-server.com/mmc/p/gd2pkz3c About...

Conference Call Today, at 10:00 a.m. Eastern Time Investor Day Scheduled for March 19, 2026, at the new Nashville, TN campus PARSIPPANY, N.J., Feb. 23, 2026 (GLOBE NEWSWIRE) — Lincoln Educational Services Corporation (Nasdaq: LINC) today announced financial and operating results for the fourth quarter and fiscal year ended December 31, 2025, as well as recent business developments. Fourth Quarter 2025 Financial and Operational HighlightsRevenue of $142.9 million, increased $23.5 million, or 19.7%; 21.4% excluding the Transitional segment Net income increased to $12.7 million, or $0.40 per share, compared to $6.8 million, or $0.22 per share last year Adjusted EBITDA of $29.1 million, increased by $9.9 million, or 51.2% Net cash flow from operations of $43.5 million, compared to $30.3 million last year Student starts grew by 15.7%...

Total 4Q and full year 2025 net product revenue of $196.0 million and $638.5 million, respectively,representing 65% and 66% year-over-year growth AUVELITY® 4Q and full year 2025 net product sales of $155.1 million and $507.1 million, respectively,representing 68% and 74% year-over-year growth SUNOSI® 4Q and full year 2025 net product revenue of $36.7 million and $124.8 million, respectively,representing 40% and 32% year-over-year growth SYMBRAVO® 4Q and full year 2025 net product sales of $4.1 million and $6.6 million, respectively sNDA for AXS-05 for the treatment of Alzheimer’s disease agitation granted Priority Review with PDUFAtarget action date of April 30, 2026 Acquired AXS-17, a novel oral GABAA α2,3 receptor positive allosteric modulator Company to host conference call today at 8:00 AM Eastern NEW...